Search results

28 items
  1. Cannabis: Classification and Public Health

    01 April 2008
    Report

    The Advisory Council on the Misuse of Drugs reviewed the classification of cannabis in the light of real public concern about the potential mental health effects of cannabis use and, in particular, the use of stronger strains of the drug.

  2. Cannabis: Classification and Public Health

    01 April 2008

    The Advisory Council on the Misuse of Drugs reviewed the classification of cannabis in the light of real public concern about the potential mental health effects of cannabis use and, in particular, the use of stronger strains of the drug.

  3. WMA warns against making essential anaesthetic a controlled drug

    06 March 2015
    Other news

    Scheduling ketamine would restrict its availability worldwide, which  would lead to harmful impact on animal health and welfare, as well on public health. The World Medical Association is urging its 111 member associations to lobby their governments to oppose scheduling the anaesthetic agent Ketamine as a controlled drug.

  4. Drug Policy Reform in Practice

    • Martin Jelsma, Tom Blickman
    25 August 2009
    Paper

    The academic journal Nueva Sociedad recently released an issue to promote the debate in Latin America on drug policy reform. TNI contributed with the paper "Drug policy reform in practice: Experiences with alternatives in Europe and the US".

  5. CND decision to schedule ketamine would undermine WHO treaty mandate

    Martin Jelsma
    16 February 2015
    Article

    The UN Commission considers to bring ketamine under the control of the 1971 Convention on Psychotropic Substances contrary to WHO recommendations. The 58th Session of the UN Commission on Narcotic Drugs (CND) in March 2015 has been asked to consider a Chinese proposal to place ketamine – an essential medicine used for anaesthesia – in Schedule I of the 1971 Convention (E/CN.7/2015/7 and E/CN.7/2015/81). Ketamine is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine under any of the 1971 treaty schedules will reduce its availability and further deepen the already acute crisis of global surgery.

  6. The development of international drug control

    • Martin Jelsma
    15 February 2011
    Policy briefing

    The emergence of more pragmatic and less punitive approaches to the drugs issue may represent the beginning of change in the current global drug control regime.

  7. European policy on khat

    • Joanne Csete
    30 April 2014

    The UK and the Netherlands commissioned distinguished scholars and experts to study the social and clinical harms of khat. These experts argued that any harms associated with khat did not require a criminal law response. In rejecting that conclusion and banning khat, these two governments have created an enabling environment for organized criminal networks and may exacerbate racial discrimination in drug law enforcement. Moreover, these policies put in danger the livelihood of thousands of people in some of the world’s lowest-income settings.

  8. Transnational Institute’s Drugs & Democracy Programme Team

    World Drug Day 2019

    26 June 2019
    Declaration

    Today marks the United Nations’ International Day Against Drug Abuse and Illicit Trafficking. Its origin can be traced back to the institutional architecture of the global drug control system which for the last five decades has served as a mechanism that regulates, controls, or prohibits the use and distribution of more than 300 psychoactive substances.

  9. The ketamine controversy, continued

    Martin Jelsma
    06 March 2015
    Opinion

    The Commission on Narcotic Drugs (CND) in Vienna will decide next week between two opposite proposals by China and the WHO about international control of ketamine, an essential anaesthetic in human and veterinary medicine. China originally proposed bringing ketamine under the 1971 Convention’s most severe control regime of Schedule I, which would dramatically affect its availability for surgery in poor rural settings and emergency situations. The WHO Expert Committee reviewed all the evidence and advised against any international control of ketamine, arguing it would trigger a public health disaster.

  10. Risk assessment of khat use in the Netherlands

    • E.J.M. Pennings, A. Opperhuizen, J.G.C. van Amsterdam
    22 August 2008
    Paper

    In preparing a decision about the legal status of khat in the Netherlands, the Dutch Minister of Health requested CAM (Coordination point Assessment and Monitoring new drugs) to assess the overall risk of khat in the Netherlands. The present paper is a redraft of a report which formed the scientific basis of the risk evaluation procedure (October 2007). This report reviews the scientific data about khat available in the international literature. In addition, the report contains some information specific for the Netherlands (prevalence, availability of khat and public order aspects).

  11. Meth Trafficking Has Exploded Throughout Asia Despite Hardline Laws

    28 May 2015
    In the media

    Vice News - Methamphetamine seizures in East Asia, Southeast Asia, and Oceania have exploded in recent years, nearly quadrupling from some 11 tons in 2008 to 42 tons in 2013, according to a report released Tuesday by the United Nations' Office on Drugs and Crime (UNODC).

  12. MDMA (‘ecstasy’)

    01 February 2008
    Report

    Due to its prevalence of use, MDMA is a significant public health issue. The Council believes that criminal justice measures will only have limited effect and strongly advises the promulgation of public health messages. It is of vital importance that issues of classification do not detract from messages concerning public health.

  13. Risk assessment of new psychoactive substances

    30 June 2009
    Report

    The principal aim of these guidelines is to put in place a sound methodological and procedural basis for carrying out each risk assessment. The risk assessment has regard to the health and social risks of the use of, manufacture of, and traffic in the new psychoactive substance, the involvement of organised crime and the possible consequences of control measures. The guidelines were finalised and adopted by the EMCDDA’s Scientific Committee in November 2008.

  14. The WHO’s First-Ever Critical Review of Cannabis

    • John Walsh, Martin Jelsma, Tom Blickman, David Bewley-Taylor
    19 March 2019
    Policy briefing

    The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD or Expert Committee) released in January 2019 the outcomes of the first-ever critical review of cannabis, recommending a series of changes in the current scheduling of cannabis-related substances under the UN drug control conventions.

  15. Fact Sheet on the Proposal to Discuss International Scheduling of Ketamine at the 58th CND

    14 February 2015

    Ketamine is an essential medicine used for anaesthesia. It is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine will leave these populations with no alternative anaesthesia for essential surgery, and will further deepen the already acute crisis of global surgery.

  16. The global political economy of scheduling

    • William B. McAllister
    26 February 2004
    Paper

    This article explains the international context of regulation to control addicting substances that gave rise to schedules. It discusses the impact of scheduling decisions on subsequent national drug control legislation and international drug control negotiations, highlighting how the creation of schedules introduced new incentives and rewards into calculations about the national/international commerce in drugs.

  17. Development of the Convention on Psychotropic Substances, 1971

    01 July 1989
    Paper

    The 196l Single Convention did not include so-called "psychotropic substances" such as amphetamines and barbiturates among the drugs controlled. The discussions on the scope of control were focused on plant-based drugs, such as cannabis, poppy cultivation, poppy straw, coca bush and coca leaves This document describes the development of an international instrument for the control of psychotropic substances.

  18. Guidance on the WHO review of psychoactive substances for international control

    17 December 2009
    Paper

    The 1961 UN Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances, entrust the Expert Committee on Drug Dependence of the World Health Organization (WHO) with the responsibility of assessing substances for abuse liability in order to make recommendations on their control under the two aforementioned Conventions.

  19. Ranking van drugs

    • J.G.C. van Amsterdam, A. Opperhuizen, M.W.J. Koeter, L.A.G.J.M. van Aerts, W. van den Brink
    30 June 2009
    Report

    In its report Ranking of drugs: A comparison of the harmful effects of drugs, the National Institute for Public Health and the Environment (RIVM) has performed a risk assessment on the harmful effects of 17 drugs plus that of tobacco and alcohol. These 19 items were ranked according to their degree of harm.

  20. Review of the UK’s Drugs Classification System

    • Crime, Drug Strategy Directorate
    01 May 2006

    The UK system of classifying drugs according to their harmfulness has been in place since the introduction of the Misuse of Drugs Act in 1971. Over the past 35 years patterns of drug use have changed quite significantly, and recent debates about the classification of certain drugs, especially cannabis, have led to questions about the clarity of the current system and whether it remains fit for purpose.

     

Pages